Noticias de AKTS_US

Noticias del mercado

Últimas noticias sobre AKTS_US — 115 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AKTS_US ✕ 115 resultados
04/05/2026 AKTS_US — Yahoo Finance
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
04/05/2026 AKTS_US — Stock Titan
Aktis opens prostate cancer study as it broadens AKY-2519 testing
04/05/2026 AKTS_US — ChartMill
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
04/05/2026 AKTS_US — ChartMill
AKTS Technical Analysis | Trend, Signals & Chart Patterns | AKTIS ONCOLOGY INC (NASDAQ:AKTS)
03/05/2026 AKTS_US — The Globe and Mail ES ← EN
Los analistas de Wall Street son optimistas sobre las principales opciones de atención médica

Wall Street Analysts Are Bullish on Top Healthcare Picks

03/05/2026 AKTS_US — Stock Titan
UCB strikes up to $2.2B Candid deal, spotlighting Two River and Vida
01/05/2026 AKTS_US — Intellectia AI
SPTX Financials: Revenue Breakdown, Margins & Competitor Comparison
30/04/2026 AKTS_US — Sahm
This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
29/04/2026 AKTS_US — Moomoo
William Blair Initiates Aktis Oncology at Outperform
29/04/2026 AKTS_US — Benzinga
This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
29/04/2026 AKTS_US — Moomoo
William Blair Initiates Aktis Oncology at Outperform
28/04/2026 AKTS_US — The Business Journals
Massachusetts biotech IPOs surge after years of drought
28/04/2026 AKTS_US — Seeking Alpha
Aktis Oncology: 'Buy' Based On Radiotherapeutic Isotope Design For Broad Targeting (AKTS)

Las acciones de Aktis Oncology (AKTS) reciben una calificación de "Compra", impulsada por sus innovadores radioconjugados de miniproteínas dirigidos a tumores sólidos Nectin-4 y B7-H3. Lea el análisis completo aquí.

25/04/2026 AKTS_US — MSN
Aktis Oncology prices IPO at $18 per share
24/04/2026 AKTS_US — MSN ES ← EN
Aktis Oncology fija el precio de su salida a bolsa a 18 dólares por acción

Aktis Oncology prices IPO at $18 per share

24/04/2026 AKTS_US — William Blair
Economics Weekly: Capacity Growth—It’s Different This Time
24/04/2026 AKTS_US — ChartMill ES ← EN
Pronóstico de AKTS, precio objetivo y calificaciones de analistas | AKTIS ONCOLOGY INC (NASDAQ:AKTS)

AKTS Forecast, Price Target & Analyst Ratings | AKTIS ONCOLOGY INC (NASDAQ:AKTS)

23/04/2026 AKTS_US — The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Intuitive Surgical (ISRG)
23/04/2026 AKTS_US — The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Intuitive Surgical (ISRG)
22/04/2026 AKTS_US — The Manila Times
Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Página 2 de 6

keyboard_arrow_up